Item 1. Interim Financial Statements.
INTERPRIVATE II ACQUISITION CORP.
CONDENSED BALANCE SHEET
| |
September 30, | | |
December 31, | |
| |
2022 | | |
2021 | |
| |
| | |
| |
ASSETS | |
| | |
| |
Current assets | |
| | |
| |
Cash | |
$ | 40,119 | | |
$ | 120,785 | |
Prepaid expenses | |
| 126,439 | | |
| 249,172 | |
Total current assets | |
| 166,558 | | |
| 369,957 | |
| |
| | | |
| | |
Prepaid expense, net of current assets | |
| — | | |
| 41,075 | |
Marketable securities held in Trust Account | |
| 260,207,445 | | |
| 258,821,242 | |
TOTAL ASSETS | |
$ | 260,374,003 | | |
$ | 259,232,274 | |
| |
| | | |
| | |
| |
| | | |
| | |
LIABILITIES AND STOCKHOLDERS’ DEFICIT | |
| | | |
| | |
Current liabilities | |
| | | |
| | |
Related party payable | |
$ | 439,279 | | |
$ | 50,320 | |
Accounts payable and accrued expenses | |
| 6,135,574 | | |
| 1,283,968 | |
Total current liabilities | |
| 6,574,853 | | |
| 1,334,288 | |
| |
| | | |
| | |
Warrant liability | |
| 236,980 | | |
| 4,115,552 | |
Total Liabilities | |
| 6,811,833 | | |
| 5,449,840 | |
| |
| | | |
| | |
Commitments and Contingencies (See Note 6) | |
| | | |
| | |
Class A common stock subject to possible redemption 25,875,000 shares at redemption value | |
| 259,963,920 | | |
| 258,821,242 | |
| |
| | | |
| | |
Stockholders’ Deficit | |
| | | |
| | |
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | |
| — | | |
| — | |
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; 200,000 shares issued and outstanding (excluding 25,875,000 shares subject to possible redemption) (1) | |
| 20 | | |
| 20 | |
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,468,750 shares issued and outstanding | |
| 647 | | |
| 647 | |
Additional paid-in capital | |
| — | | |
| — | |
Accumulated deficit | |
| (6,402,417 | ) | |
| (5,039,475 | ) |
Total Stockholders’ Deficit | |
| (6,401,750 | ) | |
| (5,038,808 | ) |
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | |
$ | 260,374,003 | | |
$ | 259,232,274 | |
The accompanying notes are an integral part of
the unaudited condensed financial statements.
INTERPRIVATE II ACQUISITION CORP.
CONDENSED STATEMENT OF OPERATIONS
(unaudited)
| |
Three Months Ended | | |
Nine Months Ended | |
| |
September 30, | | |
September 30, | |
| |
2022 | | |
2021 | | |
2022 | | |
2021 | |
| |
| | |
| | |
| | |
| |
Operating and formation costs | |
$ | 1,446,778 | | |
$ | 705,930 | | |
$ | 5,404,062 | | |
$ | 1,562,611 | |
Related party administrative fees | |
| 60,000 | | |
| 60,000 | | |
| 180,000 | | |
| 140,000 | |
Loss from operations | |
| (1,506,778 | ) | |
| (765,930 | ) | |
| (5,584,062 | ) | |
| (1,702,611 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other income (expense): | |
| — | | |
| | | |
| | | |
| | |
Change in fair value of warrant liabilities | |
| 165,867 | | |
| 734,067 | | |
| 3,878,572 | | |
| (912,766 | ) |
Offering costs attributable to warrant liabilities | |
| — | | |
| — | | |
| — | | |
| (6,835 | ) |
Interest earned on marketable securities held in Trust Account | |
| 336,544 | | |
| 30,522 | | |
| 823,607 | | |
| 54,504 | |
Unrealized gain (loss) on marketable securities held in Trust Account | |
| 1,027,141 | | |
| (14,144 | ) | |
| 983,987 | | |
| (17,547 | ) |
Other income (loss), net | |
| 1,529,552 | | |
| 750,445 | | |
| 5,686,166 | | |
| (882,644 | ) |
| |
| | | |
| | | |
| | | |
| | |
Income (loss) before taxes | |
| 22,774 | | |
| (15,485 | ) | |
| 102,104 | | |
| (2,585,255 | ) |
| |
| | | |
| | | |
| | | |
| | |
Provision for income taxes | |
| (271,311 | ) | |
| — | | |
| (322,368 | ) | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
Net loss | |
$ | (248,537 | ) | |
$ | (15,485 | ) | |
$ | (220,264 | ) | |
$ | (2,585,255 | ) |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class A common stock subject to redemption | |
| 25,875,000 | | |
| 25,875,000 | | |
| 25,875,000 | | |
| 25,875,000 | |
Basic and diluted net income (loss) per share, Class A common stock subject to redemption | |
$ | (0.01 | ) | |
$ | (0.00 | ) | |
$ | (0.01 | ) | |
$ | (0.08 | ) |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Non-redeemable common stock | |
| 6,668,750 | | |
| 6,668,750 | | |
| 6,668,750 | | |
| 6,668,750 | |
Basic and diluted net income (loss) per share, Non-redeemable common stock | |
$ | (0.01 | ) | |
$ | (0.00 | ) | |
$ | (0.01 | ) | |
$ | (0.08 | ) |
INTERPRIVATE II ACQUISITION CORP.
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS’
DEFICIT
(unaudited)
| |
Class A | | |
Class B | | |
Additional | | |
| | |
Total | |
| |
Common Stock | | |
Treasury Stock | | |
Paid-in | | |
Accumulated | | |
Stockholders’ | |
| |
Shares | | |
Value | | |
Shares | | |
Value | | |
Capital | | |
Deficit | | |
Deficit | |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| |
BALANCE – December 31, 2021 | |
| 200,000 | | |
$ | 20 | | |
| 6,468,750 | | |
$ | 647 | | |
$ | — | | |
$ | (5,039,475 | ) | |
$ | (5,038,808 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Remeasurement of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (82,286 | ) | |
| (82,286 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 19,172 | | |
| 19,172 | |
BALANCE – March 31, 2022 | |
| 200,000 | | |
| 20 | | |
| 6,468,750 | | |
| 647 | | |
| — | | |
| (5,102,589 | ) | |
| (5,101,922 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Remeasurement of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (87,583 | ) | |
| (87,583 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 9,101 | | |
| 9,101 | |
BALANCE – June 30, 2022 | |
| 200,000 | | |
| 20 | | |
| 6,468,750 | | |
| 647 | | |
| — | | |
| (5,181,071 | ) | |
| (5,180,404 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Remeasurement of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (972,809 | ) | |
| (972,809 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (248,537 | ) | |
| (248,537 | ) |
BALANCE – September 30, 2022 | |
| 200,000 | | |
$ | 20 | | |
| 6,468,750 | | |
$ | 647 | | |
$ | — | | |
$ | (6,402,417 | ) | |
$ | (6,401,750 | ) |
| |
Class A | | |
Class B | | |
Additional | | |
| | |
Total | |
| |
Common Stock | | |
Treasury Stock | | |
Paid-in | | |
Accumulated | | |
Stockholders’ | |
| |
Shares | | |
Value | | |
Shares | | |
Value | | |
Capital | | |
Deficit | | |
Deficit | |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| |
BALANCE – December 31, 2020 | |
| — | | |
$ | — | | |
| — | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Issuance of Class B common stock to Sponsor | |
| — | | |
| — | | |
| 6,468,750 | | |
| 647 | | |
| — | | |
| — | | |
| 647 | |
Issuance costs associated with the sale of Public Units | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (2,348,298 | ) | |
| (2,348,298 | ) |
Sale of 4,616,667 Private Placement Warrants | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
Issuance of Representative Shares | |
| 200,000 | | |
| 20 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 20 | |
Remeasurement of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (8,805 | ) | |
| (8,805 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 174,342 | | |
| 174,342 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
BALANCE – March 31, 2021 | |
| 200,000 | | |
| 20 | | |
| 6,468,750 | | |
| 647 | | |
| — | | |
| (2,182,761 | ) | |
| (2,182,094 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Remeasurement of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (11,775 | ) | |
| (11,775 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (2,744,112 | ) | |
| (2,744,112 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
BALANCE – June 30, 2021 | |
| 200,000 | | |
$ | 20 | | |
| 6,468,750 | | |
$ | 647 | | |
$ | — | | |
$ | (4,938,648 | ) | |
$ | (4,937,981 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Remeasurement of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (16,377 | ) | |
| (16,377 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (15,485 | ) | |
| (15,485 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
BALANCE – September 30, 2021 | |
| 200,000 | | |
$ | 20 | | |
| 6,468,750 | | |
$ | 647 | | |
$ | — | | |
$ | (4,970,510 | ) | |
$ | (4,969,843 | ) |
The accompanying notes are an integral part of
the unaudited condensed financial statements.
INTERPRIVATE II ACQUISITION CORP.
CONDENSED STATEMENT OF CASH FLOWS
(unaudited)
| |
Nine Months Ended September 30 | |
| |
2022 | | |
2021 | |
Cash flows from Operating Activities: | |
| | |
| |
Net loss | |
$ | (220,264 | ) | |
$ | (2,585,255 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
(Gain) loss on warrant liabilities | |
| (3,878,572 | ) | |
| 912,766 | |
Offering costs attributable to warrant liabilities | |
| — | | |
| 6,835 | |
Interest earned on marketable securities held in Trust Account | |
| (823,607 | ) | |
| (54,504 | ) |
Unrealized (gain) loss on marketable securities held in Trust Account | |
| (983,987 | ) | |
| 17,547 | |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses and other current assets | |
| 163,808 | | |
| (357,624 | ) |
Related party payable | |
| 388,959 | | |
| - | |
Accrued expenses | |
| 4,851,606 | | |
| 1,060,872 | |
Net cash used in operating activities | |
| (502,057 | ) | |
| (999,363 | ) |
| |
| | | |
| | |
Cash flows from Investing Activities: | |
| | | |
| | |
Investment in trust account | |
| — | | |
| (258,750,000 | ) |
Withdrawals from Trust Account | |
| 421,391 | | |
| — | |
Net cash provided by (used in) investing activities | |
| 421,391 | | |
| (258,750,000 | ) |
| |
| | | |
| | |
Cash flows from Financing Activities: | |
| | | |
| | |
Proceeds from sale of Units, net of underwriting discounts paid | |
| — | | |
| 253,575,000 | |
Proceeds from sale of Private Placement Warrants | |
| — | | |
| 6,925,000 | |
Proceeds from promissory note – related party | |
| — | | |
| 149,476 | |
Repayment of promissory note – related party | |
| — | | |
| (149,476 | ) |
Payment of offering costs | |
| — | | |
| (502,651 | ) |
Net cash provided by financing activities | |
| — | | |
| 259,997,349 | |
| |
| | | |
| | |
Net Change in Cash | |
| (80,666 | ) | |
| 247,986 | |
Cash – Beginning of period | |
| 120,785 | | |
| — | |
| |
| | | |
| | |
Cash – End of period | |
$ | 40,119 | | |
$ | 247,986 | |
| |
| | | |
| | |
Non-Cash investing and financing activities: | |
| | | |
| | |
Offering costs paid by Sponsor in exchange for issuance of Founder Shares | |
$ | - | | |
$ | 25,000 | |
Issuance of Representative Shares | |
$ | - | | |
$ | 20 | |
Remeasurement in value of common stock subject to redemption | |
$ | (1,142,679 | ) | |
$ | (36,957 | ) |
The accompanying notes are an integral part of
the unaudited condensed financial statements.
INTERPRIVATE II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS
InterPrivate II Acquisition Corp. (the “Company”)
is a blank check company incorporated in Delaware on September 10, 2020. It was originally incorporated under the name “InterPrivate
IV Capital Partners Corp.”, but the Company changed its name to “InterPrivate II Acquisition Corp.” on January 6, 2021.
The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or other similar business combination with one or more businesses (each, a “Business Combination”).
The Company is not limited to a particular industry
or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such,
the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of September 30, 2022, the Company had not
commenced any operations. All activity through September 30, 2022 relates to the Company’s formation, its initial public offering
(the “Initial Public Offering”), and subsequent to the Initial Public Offering, identifying a target company for a Business
Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the
earliest. The Company will generate non-operating income on cash and cash equivalents in the form of interest income from the proceeds
derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.
Risks and Uncertainties
Management continues to evaluate the impact of
the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s
financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial
statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain
information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or
omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, the financial statements do not
include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash
flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of
a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for
the periods presented.
The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as
filed with the SEC on March 31, 2022 (the “Annual Report”). The interim results for the three and nine months ended September
30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.
There have been no changes to our significant
accounting policies described in our Annual Report that have had a material impact on our condensed financial statements and related notes.
Reclassifications
Certain reclassifications were made to the prior
period balances to conform to the current period presentation. These reclassifications do not restate the prior period financial statements
and are for presentation purposes only.
Liquidity and Financial Condition
As of September
30, 2022 the company had cash of $40,119 and a working capital deficit of $6,164,771.
The Company will need to raise additional capital through loans or additional investments from its initial stockholders, officers or directors.
The Sponsor is authorized to issue to up to $1.5M to the Company through a Working Capital Loan.
If the Company is unable to raise additional capital, the Company may
be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations,
suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing
will be available to the Company on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s
ability to continue as a going concern through one year and one day from the issuance of this report. The Company has a termination date
of less than one year from the issuance of this report.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements and compliance with new or revised financial accounting
standards that are applicable to other public companies.
Use of Estimates
The preparation of the condensed financial statements
in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents
as of September 30, 2022 and December 31, 2021.
Marketable Securities Held in Trust Account
At September 30, 2022, substantially all of the
assets held in the Trust Account were invested in U.S. Treasury Bills.
Class A Common Stock Subject to Possible
Redemption
The Company accounts for its Class A common stock
subject to possible redemption in accordance with the guidance in ASC 480. Accordingly, at September 30, 2022, Class A common stock subject
to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance
sheet.
Income Taxes
The Company complies with the accounting and reporting
requirements of ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial
accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial
statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws
and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established,
when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and
a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax
return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were
no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company
is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is subject to income tax examinations by major taxing authorities since inception.
The Company’s effective tax rate was 1,191.30% and 0% for the
three months ended September 30, 2022 and 2021, respectively, and 315.73% and 0% for the nine months ended September 30, 2022 and 2021,
respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022
and 2021, due to changes in fair value in warrant liability and the valuation allowance on the deferred tax assets.
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR
Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases
of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations
occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which
shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of
the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value
of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions
apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations
and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Net Loss Per Share of Common Stock
The Company
complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share” (“ASC Topic 260”).
Net income (loss) per common share is computed by dividing net income by the weighted average number of common shares outstanding for
the period. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption
value approximates fair value.
The following table reflects the calculation of
basic and diluted net income (loss) per common share (in dollars, except per share amounts):
| | For the Three Months Ended September 30, | | | For the Nine Months Months Ended September 30, | |
| | 2022 | | | 2021 | | | 2022 | | | 2021 | |
Ordinary shares subject to possible redemption | | | | | | | | | | | | |
| | | | | | | | | | | | |
Numerator: | | | | | | | | | | | | |
Net loss attributable to Class A common stock subject to possible redemption | | $ | (197,608 | ) | | $ | (12,312 | ) | | $ | (175,128 | ) | | $ | (2,055,494 | ) |
Denominator: Weighted Average Class A | | | | | | | | | | | | | | | | |
Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption | | | 25,875,000 | | | | 25,875,000 | | | | 25,875,000 | | | | 25,875,000 | |
Basic and Diluted net loss per share, Redeemable Ordinary Shares | | $ | (0.01 | ) | | $ | (0.00 | ) | | $ | (0.01 | ) | | $ | (0.08 | ) |
| | | | | | | | | | | | | | | | |
Non-Redeemable ordinary shares | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Numerator: | | | | | | | | | | | | | | | | |
Net loss | | $ | (248,537 | ) | | $ | (15,485 | ) | | $ | (220,264 | ) | | $ | (2,585,255 | ) |
Less: Net loss attributable to Class A common stock subject to possible redemption | | | 197,608 | | | | 12,312 | | | | 175,128 | | | | 2,055,494 | |
Net loss attributable to Class A common stock not subject to possible redemption | | | (50,929 | ) | | | (3,173 | ) | | | (45,136 | ) | | | (529,761 | ) |
Denominator: Weighted Average Non-Redeemable | | | | | | | | | | | | | | | | |
Basic and diluted weighted average shares outstanding, non-redeemable common stock | | | 6,668,750 | | | | 6,668,750 | | | | 6,668,750 | | | | 6,668,750 | |
Basic and diluted net loss per share, Non-redeemable common stock | | $ | (0.01 | ) | | $ | (0.00 | ) | | $ | (0.01 | ) | | $ | (0.08 | ) |
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed
financial statements.
NOTE 3. PUBLIC OFFERING
There have been no changes to the public offering
amounts previously disclosed in the December 31, 2021 financials. As of September 30, 2022, cash of $40,119 was held outside of the Trust
Account and was available for working capital purposes.
NOTE 4. PRIVATE PLACEMENT
There have been no changes to the private placement
warrant disclosure since the December 31, 2021 financials.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On January 13, 2021, the Sponsor paid $25,000
to cover certain offering costs of the Company in consideration for 5,750,000 shares of Class B common stock (the “Founder Shares”).
On February 4, 2021, the Sponsor transferred an aggregate 90,000 Founder Shares to the Company’s independent directors, resulting
in the Sponsor holding 5,660,000 Founder Shares. On March 4, 2021, the Company effected a 1.125-for-1 stock split of its Class B common
stock, resulting in an aggregate of 6,468,750 Founder Shares issued and outstanding, 6,378,750 of which were held by the Sponsor. On November
22, 2021, the Sponsor transferred 30,000 Founder Shares to a newly appointed independent director of the Company, resulting in the Sponsor
holding 6,348,750 Founder Shares. The aggregate value of the 120,000 Founder Shares transferred to the independent directors will be recorded
as compensation expense at the time of a Business Combination. The initial grant was deemed de minimis and the second grant in November
2021 is estimated at $9.79 per share, approximately $300,000. The Founder Shares included an aggregate of up to 843,750 shares subject
to forfeiture. As a result of the underwriters’ election to fully exercise their over-allotment option, no Founder Shares were subject
to forfeiture.
Administrative Services Agreement
The Company entered into an agreement, commencing
on March 4, 2021, pursuant to which the Company will pay the Sponsor a total of $10,000 per month for office space, administrative and
support services. Upon completion of the Business Combination or the Company’s liquidation, the agreement will terminate, and the
Company will cease paying these monthly fees. For the three months ended September 30, 2022 and 2021, the Company recorded $30,000 and
$30,000, respectively, in fees for these services. For the nine months ended September 30, 2022 and 2021, the Company recorded $90,000
and $70,000, respectively, in fees for these services. As of September 30, 2022 and December 31, 2021, the service fee payable was $0,
respectively. Payments were reimbursed through the related party payable on the accompanying condensed balance sheets.
Convertible Promissory Note — Related
Party
On March 31, 2022, the Company entered into a
convertible promissory note with the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $1,500,000
(the “Convertible Promissory Note”). The Convertible Promissory Note is non-interest bearing and due on the earlier of March
9, 2023 and the date on which the Company consummates its initial business combination. If the Company completes a business combination,
it would repay such additional loaned amounts, without interest, upon consummation of the business combination. In the event that a business
combination does not close, the Company may use a portion of the working capital held outside the trust account to repay such additional
loaned amounts but no proceeds from the trust account would be used for such repayment. Up to $1,500,000 of such additional loans (if
any) may be convertible into warrants, at a price of $1.50 per warrant at the option of the Sponsor. The warrants would be identical to
the private placement warrants, including as to exercise price, exercisability and exercise period. Except for the foregoing, the terms
of such additional loans (if any) have not been determined and no written agreements exist with respect to such loans. If the Company
fully draws down on the Convertible Promissory Note and requires additional funds for working capital purposes, the Sponsor, an affiliate
of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company such additional funds as
may be required. The issuance of the Convertible Promissory Note was approved by the board of directors and the audit committee on March
31, 2022. As of September 30, 2022, there was $0 outstanding under the Convertible Promissory Note which is reported in related party
payables.
Related Party Loans
In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may,
but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). The Working Capital Loans would
either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000
of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant.
The warrants would be identical to the Private Placement Warrants.
In addition, as the Company incurs operating expenses,
these fees are paid by InterPrivate LLC, and InterPrivate LLC is subsequently reimbursed by the Company for the full amount paid. As of
September 30, 2022 and December 31, 2021, the Company had $439,279 and $50,320 in related party payables outstanding, respectively. The
increase is primarily due to increased invoices paid by the LLC on behalf of InterPrivate II for operations.
Services Agreement
The Company entered into an agreement, pursuant to which the Company
will pay its Vice President a total of $10,000 per month for assisting the Company in negotiating and consummating an initial Business
Combination. Upon completion of the Business Combination or the Company’s liquidation, the agreement will terminate, and the Company
will cease paying these monthly fees. For the three months ended September 30, 2022 and 2021, the Company incurred $30,000 and $30,000
in fees, respectively, for these services. For the nine months ended September 30, 2022 and 2021, the Company incurred $90,000 and $70,000
in fees, respectively, for these services. As of September 30, 2022 and December 31, 2021, the service fee payable was $0 and $0, respectively.
Payments were reimbursed through the related party payable on the accompanying condensed balance sheets.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration Rights
Pursuant to a registration rights agreement entered
into on March 4, 2021, the holders of the Founder Shares, Representative Shares, Private Placement Warrants and any warrants that may
be issued upon conversion of the Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private
Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) have registration rights requiring the Company
to register a sale of any of the securities held by them prior to the consummation of a Business Combination. The holders of these securities
will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In
addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent
to the completion of a Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement
provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.
Business Combination Marketing Agreement
In conjunction with the Initial Public Offering, the Company entered
into a Business Combination Marketing Agreement (the “BCMA”) under which the Company engaged Morgan Stanley and EarlyBirdCapital
as advisors in connection with the Business Combination to assist the Company in holding meetings with its stockholders to discuss the
potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested
in purchasing the Company’s securities in connection with the Business Combination, assist the Company in obtaining stockholder
approval for the Business Combination, and assist the Company with its press releases and public filings in connection with the Business
Combination. Under the BCMA, the Company agreed to pay Morgan Stanley and EarlyBirdCapital a cash fee for such services upon the consummation
of a Business Combination in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering, or $9,056,250 (exclusive of
any applicable finders’ fees which might become payable).
On July 5, 2022, Morgan Stanley entered into a
letter agreement with the Company and EarlyBirdCapital that amended the BCMA by (i) removing Morgan Stanley as a party to the BCMA and
releasing it from its obligations thereunder; (ii) stating that Morgan Stanley would no longer have any rights, benefits, liabilities
or obligations thereunder; (iii) reducing the fee payable thereunder from 3.5% to 1.75% of the gross proceeds of the Initial Public Offering
(such reduced amount totaling $4,528,125), which becomes payable solely to EarlyBirdCapital on the condition that the Company successfully
completes a business combination transaction; and (iv) obligating the Company to indemnify Morgan Stanley for any claims arising out of
the letter agreement and to continue to indemnify Morgan Stanley as provided under the BCMA. As a result of such letter agreement, Morgan
Stanley is no longer required to perform any services under the BCMA and is not entitled to receive any compensation thereunder. The letter
agreement did not amend the provision of the BCMA which provides that the full amount of the original BCMA Fee (totaling $9,056,250) will
be returned to the Public Stockholders upon the Company’s liquidation if the Company does not consummate a Business Combination
within 24 months of the Initial Public Offering (or any extension thereof).
NOTE 7. WARRANTS
There have been no changes to the public warrant
disclosure since the Annual Report on Form 10-K.
NOTE 8. FAIR VALUE MEASUREMENTS
The Company follows the guidance in ASC 820 for
its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets
and liabilities that are re-measured and reported at fair value at least annually.
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
|
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
|
|
|
|
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
|
|
|
|
Level 3: |
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
The following tables present information about
the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021, respectively,
and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
| |
| | |
September 30, | |
Description | |
Level | | |
2022 | |
Assets: | |
| | |
| |
Marketable securities held in Trust Account | |
| 1 | | |
$ | 260,207,445 | |
| |
| | | |
| | |
Liabilities: | |
| | | |
| | |
Warrant liability - Private placement warrants | |
| 3 | | |
| 231,000 | |
Warrant liability - Underwriters warrants | |
| 3 | | |
| 5,980 | |
| |
| | |
December 31, | |
Description | |
Level | | |
2021 | |
Assets: | |
| | |
| |
Marketable securities held in Trust Account | |
| 1 | | |
$ | 258,821,242 | |
| |
| | | |
| | |
Liabilities: | |
| | | |
| | |
Warrant liability - Private placement warrants | |
| 3 | | |
| 3,584,971 | |
Warrant liability - Underwriters warrants | |
| 3 | | |
| 530,581 | |
The Private Placement Warrants were initially
valued using a Binomial Lattice Model, which is considered to be a Level 3 fair value measurement. The Binomial Lattice Model’s
primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the
common stock. The expected volatility as of the IPO date was derived from observable public warrant pricing on comparable ‘blank-check’
companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s
own public warrant pricing. A Binomial Lattice Model was used in estimating the fair value of the Private Placement Warrants for periods
where no observable traded price was available.
The key inputs into the Binomial Lattice Model
for the initial measurement of the Private Placement Warrants, and the subsequent measurement of the Private Placement Warrants, are as
follows:
| |
September 30, | | |
December 31, | |
Term | |
2022 | | |
2021 | |
Risk-free interest rate | |
| 4.20 | % | |
| 1.19 | % |
Market price of public stock | |
$ | 9.84 | | |
$ | 9.70 | |
Dividend yield | |
| 0.00 | % | |
| 0.00 | % |
Implied volatility | |
| 2.80 | % | |
| 16.6 | % |
Exercise price | |
$ | 11.50 | | |
$ | 11.50 | |
The above assumptions are based on an expected
close of a de-SPAC transaction on December 31, 2022.
On September 30, 2022 and December 31, 2021, the
Private Placement Warrants were determined to be valued at $0.06 and $0.93 per warrant, respectively. On September 30, 2022 and December
31, 2021, the Underwriter Warrants were valued at $0.01 and $0.69, respectively.
The following table presents the changes in the
fair value of warrant liabilities:
Term | |
Private
Placement | | |
Underwriters
Warrants | |
Fair value as of December 31, 2021 | |
$ | 3,584,971 | | |
$ | 530,581 | |
Change in valuation inputs or other assumptions | |
| (3,353,971 | ) | |
| (524,601 | ) |
Fair value as of September 30, 2022 | |
$ | 231,000 | | |
$ | 5,980 | |
During the nine-month period ended September 30,
2022, there were no transfers out of Level 3.
NOTE 9. SUBSEQUENT EVENTS
On October 31, 2022, the Sponsor and Braemar Energy
Ventures III, L.P. (“Braemar”) entered into a Stock Transfer Agreement pursuant to which the Sponsor agreed to transfer 200,000
shares of Class A Stock to Braemar promptly following, and contingent upon, the Closing of the Business Combination.
Pursuant to the terms of the Merger Agreement and a letter agreement
entered into on November 7, 2022 between the Company and Getaround (the “Escrow Shares Allocation Agreement”), the Escrow
Shares will be allocated promptly following the Closing to: (i) non-redeeming public holders of Class A Stock, whether acquired in InterPrivate
II’s initial public offering or acquired in the secondary market (the “Public Stockholders”), (ii) the designees of
EarlyBirdCapital, and (iii) the holders of the Class B Stock including the Sponsor and the current and former independent directors of
InterPrivate II (collectively, the “Bonus Share Recipients”, and the Escrow Shares entitled to be received by the Bonus Share
Recipients, the “Bonus Shares”). The Bonus Shares will be apportioned pro rata to each Bonus Share Recipient based on the
number of shares of Class A Stock held immediately following the Closing as a percentage of the total number of shares of Class A Stock
that remain outstanding after giving effect to redemptions and the automatic conversion of the Founder Shares into shares of Class A Stock.
However, the holders of the Representative Shares and the Founder Shares (collectively, the “Initial Stockholders”) have agreed
pursuant to the Escrow Shares Allocation Agreement to re-allocate to the Getaround equityholders the number of Bonus Shares which exceed
the number that the Initial Stockholders would have received on a pro rata basis if no Public Stockholders elect to exercise their redemption
rights.
Item 2. Management’s Discussion and Analysis
of Financial Condition and Results of Operations
References in this quarterly report on Form 10-Q
(the “Quarterly Report”) to “we,” “us” or the “Company” refer to InterPrivate II Acquisition
Corp. References to our “management” or our “management team” refer to our officers and directors, and references
to the “Sponsor” refer to InterPrivate Acquisition Management II, LLC. The following discussion and analysis of the Company’s
financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained
elsewhere in this Quarterly Report and the Annual Report. Certain information contained in the discussion and analysis set forth below
includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”) that are not historical facts and involve risks and uncertainties that could cause actual
results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this
Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition
and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management
for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,”
“intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify
such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s
current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ
materially from the events, performance and results discussed in the forward-looking statements. For information identifying important
factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to
the Risk Factors section of the Annual Report. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s
website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to
update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company formed under the
laws of the State of Delaware on September 10, 2020 for the purpose of effectuating a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or other similar business combination with one or more businesses. We intend to effectuate our Business
Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our capital stock,
debt or a combination of cash, stock and debt.
We expect to continue to incur significant costs
in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Proposed Transaction
On May 11, 2022, the Company, TMPST Merger Sub
I Inc., a Delaware corporation and newly formed, wholly-owned direct subsidiary of the Company (“First Merger Sub”), TMPST
Merger Sub II LLC, a Delaware limited liability company and newly formed, wholly-owned direct subsidiary of the Company (“Second
Merger Sub”), and Getaround, Inc., a Delaware corporation (“Getaround”), entered into an Agreement and Plan of Merger
(the “Merger Agreement”). If the Merger Agreement and the transactions contemplated thereby are adopted and approved by the
Company’s stockholders (and the other closing conditions are satisfied or waived in accordance with the Merger Agreement), and the
business combination is subsequently completed, (a) First Merger Sub will merge with and into Getaround (the “First Merger”),
with Getaround being the surviving corporation of the First Merger, and (b) immediately following the First Merger, Getaround will merge
with and into Second Merger Sub (the “Second Merger” and, together with the First Merger, the “Mergers” and, collectively
with the Mergers and other transactions described in the Merger Agreement, the “Proposed Transaction”), with Second Merger
Sub being the surviving company of the Second Merger. In addition, in connection with the consummation of the Proposed Transaction (the
“Closing”), the Company will be renamed “Getaround, Inc.” and is referred to herein as “Pubco.”
Under the Merger Agreement, holders of Getaround’s
equity interests are expected to receive approximately $800,000,000 (“the Base Purchase Price”) in aggregate consideration
in the form of Pubco Class A common stock, par value $0.0001 per share (“Pubco Class A Common Stock”), equal to the quotient
obtained by dividing (i) the Base Purchase Price by (ii) the per share price of $10.00 at the Closing. In
addition to the Base Purchase Price, Pubco will issue up to an additional 34,000,000
shares of Pubco Class A Common Stock up to an additional 11,000,000 shares of Pubco Class A Common
Stock to certain personnel of Getaround as earnout consideration in tranches based upon the volume weighted average price of Pubco Class
A Common Stock for any twenty trading days within a period of thirty consecutive trading days at any time following the Closing until
the seven year anniversary of the Closing. These price targets range from $13.50 to $55.
9,333,333
shares of Pubco Class A Common Stock issuable as part of the Base Purchase Price will be set aside in an escrow account at Closing (the
“Escrow Shares”). 1,000,000 Escrow Shares will be set aside and allocated as agreed upon by the Company and Getaround, including
for the benefit of public stockholders who do not redeem their Class A common stock in connection with the Proposed Transaction (the “Non-Redeeming
Public Holders”). In the event of a PIPE Investment (as defined below), a number of Escrow Shares equal to (i) 8,333,333 multiplied
by (ii) a fraction, (A) the numerator of which will be the lesser of (y) the PIPE Investment Amount (as defined below) and (z) $125,000,000
and (B) the denominator of which will be $125,000,000 (the “PIPE Protection Shares”), will be set aside for the benefit of
the PIPE investors. Further, a remaining portion of the Escrow Shares, including any remaining PIPE Protection Shares not allocated will
be set aside and allocated as agreed upon by the Company and Getaround, including, in case the PIPE Investment Amount is less than $125,000,000,
for the benefit of some or all of the Non-Redeeming Public Holders.
Pursuant to the terms of the Merger Agreement
and a letter agreement entered into on November 7, 2022 between the Company and Getaround (the “Escrow Shares Allocation Agreement”),
the Escrow Shares will be allocated promptly following the Closing to: (i) non-redeeming public holders of Class A Stock, whether acquired
in InterPrivate II’s initial public offering or acquired in the secondary market (the “Public Stockholders”), (ii) the
designees of EarlyBirdCapital, and (iii) the holders of the Class B Stock including the Sponsor and the current and former independent
directors of InterPrivate II (collectively, the “Bonus Share Recipients”, and the Escrow Shares entitled to be received by
the Bonus Share Recipients, the “Bonus Shares”). The Bonus Shares will be apportioned pro rata to each Bonus Share Recipient
based on the number of shares of Class A Stock held immediately following the Closing as a percentage of the total number of shares of
Class A Stock that remain outstanding after giving effect to redemptions and the automatic conversion of the Founder Shares into shares
of Class A Stock. However, the holders of the Representative Shares and the Founder Shares (collectively, the “Initial Stockholders”)
have agreed pursuant to the Escrow Shares Allocation Agreement to re-allocate to the Getaround equityholders the number of Bonus Shares
which exceed the number that the Initial Stockholders would have received on a pro rata basis if no Public Stockholders elect to exercise
their redemption rights.
In connection with the Closing, the Founder Shares
will automatically convert into shares of Pubco Class A Common Stock on a one-for-one basis and will continue to be subject to the transfer
restrictions applicable to the Founder Shares.
The Merger Agreement contains customary representations
and warranties, covenants and closing conditions, including, but not limited to, approval by the Company’s stockholders of the Merger
Agreement and the Proposed Transaction. The terms of the Merger Agreement and other related ancillary agreements entered into or to be
entered into in connection with the Closing of the Proposed Transaction, including those briefly described below, are summarized in more
detail in the Company’s Form 8-K filed with the SEC on May 13, 2022.
Convertible Notes
In connection with the execution of the Merger
Agreement, the Company entered into a subscription agreement (the “Subscription Agreement”) with an investor to purchase convertible
promissory notes (the “Convertible Notes”) in an aggregate principal amount of at least $100 million, up to a maximum of $175
million under certain conditions. The Convertible Notes will be convertible into shares of Pubco Class A Common Stock (subject to adjustments
as provided in the indenture governing the Convertible Notes) at an initial conversion rate of 86.96 shares of Pubco Class A Common Stock
per $1,000 principal amount of Convertible Notes, representing an initial conversion price of $11.50 per share, subject to a downward
adjustment to 115% of the average daily VWAP of Pubco Class A Common Stock for the 90 trading days after the Closing Date, subject to
a minimum conversion price of $9.21 per share, subject to adjustments to such rate as provided in the indenture, including adjustments
in connection with certain issuances or deemed issuances of Pubco Class A Common Stock at a price less than the then-effective conversion
price, at any time prior to the close of business on the second scheduled trading day immediately before the maturity date of the Convertible
Notes. In connection with the execution of the Subscription Agreement for the purchase of the Convertible Notes, the Company agreed to
issue warrants (the “Notes Warrants”), each representing the right to purchase one share of Pubco Class A Common Stock, that
are exercisable for shares of Pubco Class A Common Stock having an aggregate value equal to $3.5 million, based upon a value of $1.25
per Note Warrant; provided that such value shall be adjusted upward or downward to reflect the VWAP reported by Bloomberg LP (subject
to customary proportionate adjustments affecting the outstanding shares of Pubco Class A Common Stock) of the equivalent publicly-traded
warrants of the Company during the 90 trading days following the Closing Date, subject to a maximum upward or downward adjustment of $0.75
per Note Warrant. Notwithstanding the foregoing, the Company shall have the right to pay cash in lieu of issuing the Note Warrants; provided
that such cash amount will be equal to $3.5 million. The Company also agreed to pay the investor within 100 trading days following the
Closing Date, a fee equal to $5.25 million.
The Company’s obligations under the Convertible
Notes will be (a) guaranteed by second Merger Sub and certain of its and the Company’s subsidiaries and (b) secured by collateral
consisting of substantially all of the assets of Pubco and its subsidiary guarantors pursuant to security documents to be entered into
upon the issuance of the Convertible Notes.
The Convertible Notes will bear interest at the
rate of 8.00% per annum if Pubco elects to pay interest in cash or 9.50% per annum if Pubco elects to pay interest in-kind, and interest
will be paid semi-annually. Upon the occurrence, and during the continuation, of an event of default, an additional 2.00% will be added
to the stated interest rate. The Convertible Notes will mature on the fifth anniversary of issuance and will be redeemable at any time
by Pubco, in whole but not in part, for cash, at par plus accrued and unpaid interest to, but excluding, the redemption date, plus, certain
make-whole premiums as specified in the indenture governing the Convertible Notes.
Upon the occurrence of a Fundamental Change (as
defined in the indenture governing the Convertible Notes), the investor will have the right, at its option, to require Pubco to repurchase
for cash all or any portion of its Convertible Notes in principal amounts of $1,000 or an integral multiple thereof, at a fundamental
change repurchase price equal to the principal amount of the Convertible Notes to be repurchased plus certain make-whole premiums, plus
accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the Convertible Notes will include restrictive
covenants that, among other things, will limit the ability of Pubco to incur additional debt, make restricted payments and limit the ability
of Pubco to incur liens. The indenture will also contain customary events of default.
In addition to the customary conditions to closing
provided in the Subscription Agreement, the obligations of the investor to purchase the Convertible Notes are conditioned upon, among
other things, and are expected to close concurrently with, the consummation of the Mergers.
PIPE Investment
The Company and Getaround anticipate that after
the execution of the Merger Agreement, certain investors will agree to make private investments in the Company (the “PIPE Investment”)
in an aggregate amount to be mutually agreed by the Company and Getaround (the “PIPE Investment Amount”), which amount will
exclude any amount raised pursuant to the Subscription Agreement described above, to purchase shares of Pubco Class A Stock to be consummated
immediately prior to the consummation of the Proposed Transaction, on the terms and subject to the conditions of the subscription agreements
to be executed and delivered by the Company and the investors.
Getaround Holders Support Agreement
Certain stockholders of Getaround will enter into
a support agreement with the Company and Getaround, pursuant to which, among other things, such holders will agree to provide an executed
irrevocable written consent approving the Proposed Transaction within forty-eight hours after the execution of the Merger Agreement.
Sponsor Support Agreement
Concurrently with the execution of the Merger
Agreement, the Sponsor entered into a sponsor support agreement (the “Sponsor Support Agreement”) with the Company and Getaround,
pursuant to which the Sponsor agreed to, among other things, vote in favor of the Merger Agreement and the Proposed Transaction.
Registration Rights and Lock-Up Agreement
In connection with the consummation of the First
Merger, the Company, the Sponsor and Jeffrey Harris, Matthew Luckett and Tracey Brophy Warson (the “Sponsor Holders”), EarlyBird
Capital and certain equity holders of Getaround (the “Legacy Holders” and, together with the Sponsor Holders and EarlyBird
Capital, the “Holders”) will enter into an Amended and Restated Registration Rights Agreement. Pursuant to the terms of the
Amended and Restated Registration Rights Agreement, (a) the Holders will be granted registration rights with respect to their respective
Pubco shares, and (b) the Sponsor Holders and the Legacy Holders will agree not to effect any sale or distribution of certain equity securities
of Pubco held by any of them during the lock-up period described therein in each case, on the terms and subject to the conditions set
forth therein.
Results of Operations
We have neither engaged in any operations nor
generated any revenues to date. Our only activities through September 30, 2022 were organizational activities, those necessary to prepare
for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate
any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest
income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial
reporting, accounting and auditing compliance), as well as for due diligence expenses.
The three months ended September 30, 2022
compared to the three months ended September 30, 2021
For the three months ended September 30, 2022 and 2021, we had a net
loss of $248,537 versus a net loss of $15,485, respectively, a change of $233,052. This change was primarily driven by increases in operating
costs of $740,848 and an offset of $568,200 for changes in fair value of warrant liabilities and an increase in the provision for income
taxes of $271,311. We recorded income for the change in fair value of warrant liabilities of $165,867 for the three months ended September
30, 2022 compared to $734,067 for the three months ended September 30, 2021. The change in fair value of warrant liabilities is due to
the decrease in warrant values from an ending balance of $ 4,115,552 as of December 31, 2021 to $ 236,980 as of September 30,
2022 as a result of current market conditions.
Period-to-period changes in our results also include
interest income on marketable securities held in the Trust Account for the three months ended September 30, 2022 of $336,544 compared
to $30,522 for the three months ended September 30, 2021, and we had an unrealized gain on marketable securities held in the Trust Account
for the three months ended September 30, 2022 of $1,027,141 compared to an unrealized loss of $14,144 for the three months ended September
30, 2021.
The nine months ended September 30, 2022
compared to the nine months ended September 30, 2021
For the nine months ended September 30, 2022 and, 2021, we had a net
loss of $220,264 versus a net loss of $2,585,255, respectively, a change of $2,364,991. This change was primarily driven by increases
in operating costs of $3,881,451 and an offset of $4,791,338 for changes in fair value of warrant liabilities, and an increase in the
provision for income taxes of $322,368. There were no warrant transaction costs for the nine months ended September 30, 2022 compared
to $6,835 for the nine months ended September 30, 2021. We recorded income for the change in fair value of warrant liabilities of $3,878,572
for the nine months ended September 30, 2022 compared to a loss of $912,766 for the nine months ended September 30, 2021.
Period-to-period changes in our results also include
interest income on marketable securities held in the Trust Account for the nine months ended September 30, 2022 of $823,607 compared to
$54,504 for the nine months ended September 30, 2021, and we had an unrealized gain on marketable securities held in the Trust Account
for the nine months ended September 30, 2022 of $983,987 compared to an unrealized loss of $17,547 for the nine months ended September
30, 2021.
Liquidity and Capital Resources
On March 9, 2021, we consummated the Initial Public
Offering of 25,875,000 Units which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,375,000
Units, at $10.00 per Unit, generating gross proceeds of $258,750,000. Simultaneously with the closing of the Initial Public Offering,
we consummated the sale of 4,616,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant in a private placement
to the Sponsor and EarlyBirdCapital, generating gross proceeds of $6,925,000.
For the nine months ended September 30, 2022, cash used in operating
activities was $502,057. Net loss of $220,264 was affected by a non-cash income related to the change in warrant liability of $3,878,572,
interest earned on marketable securities held in the Trust Account of $823,607 and an unrealized loss on marketable securities held in
in the Trust Account of $983,987. Changes in operating assets and liabilities used $5,404,373 of cash for operating activities primarily
due to accrued expenses.
As of September 30, 2022, we had marketable securities
held in the Trust Account of $260,207,445 including interest income of $823,607 and unrealized losses of $983,987 consisting of U.S. Treasury
Bills with a maturity of 185 days or less. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through
September 30, 2022, we have withdrawn $ 421,391 from the Trust Account related to payments for Delaware franchise taxes and federal
income taxes.
We intend to use substantially all of the funds
held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete
our Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our
Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the
target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2022, we had cash of $40,119
held outside the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses,
perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective
target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses,
and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their
affiliates may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants
at a price of $1.50 per warrant, at the option of the lender. The warrants would be identical to the Private Placement Warrants.
We will need to raise additional capital through
loans or additional investments from our initial stockholders, officers or directors. If we are unable to raise additional capital, we
may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing
operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new
financing will be available to us on commercially acceptable terms, if at all. These conditions raise substantial doubt about our ability
to continue as a going concern through one year and one day from the issuance of this report.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities
that would be considered off-balance sheet arrangements as of September 30, 2022. We do not participate in transactions that create relationships
with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established
for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $10,000
for office space, administrative and support services. We began incurring these fees on March 4, 2021 and will continue to incur these
fees monthly until the earlier of the completion of the Business Combination and our liquidation.
We have entered into an agreement, pursuant to
which we will pay the Vice President a total of $10,000 per month for assisting us in negotiating and consummating an initial Business
Combination. Upon completion of the Business Combination or the Company’s liquidation, the agreement will terminate and the Company
will cease paying these monthly fees.
We engaged EarlyBirdCapital as our advisor in
connection with the Business Combination to assist us in holding meetings with our stockholders to discuss the potential Business Combination
and the target business’ attributes, introduce us to potential investors that are interested in purchasing our securities in connection
with the Business Combination, assist us in obtaining stockholder approval for the Business Combination, and assist us with its press
releases and public filings in connection with the Business Combination. On July 5, 2022, the BCMA was amended, and as a result Morgan
Stanley is no longer required to perform any services under the BCMA and is not entitled to receive any compensation thereunder. We will
pay EarlyBirdCapital a cash fee for such services upon the consummation of a Business Combination in an amount equal to 1.75% of the gross
proceeds of the Initial Public Offering (exclusive of any applicable finders’ fees which might become payable).
We have issued to EarlyBirdCapital, and/or its
designees, 200,000 representative shares (the “representative shares”) for nominal consideration. The holders of the representative
shares have agreed not to transfer, assign or sell any such shares without our prior consent until the completion of our initial business
combination. In addition, the holders of the representative shares have agreed (i) to waive their conversion rights (or right to participate
in any tender offer) with respect to such shares in connection with the completion of our initial business combination and (ii) to waive
their rights to liquidating distributions from the Trust Account with respect to such shares if we fail to complete our initial business
combination within 24 months from the closing of the Public Offering.
Critical Accounting Policies
The preparation of condensed financial statements
and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses
during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting
policies:
Warrant Classification
We account for warrants as either equity-classified
or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance
in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing
Liabilities from Equity” (“ASC 480”) and ASC Topic 815, “Derivatives and Hedging” (“ASC 815”).
The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability
pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether
the warrants are indexed to the Company’s own shares of common stock and whether the warrant holders could potentially require “net
cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This
assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly
period end date while the warrants are outstanding. As of September 30, 2022 and December 31, 2021, the Private Placement Warrants were
accounted for as liabilities, and the Public Warrants were accounted for as temporary equity.
Common Stock Subject to Possible Redemption
We account for our common stock subject to possible
conversion in accordance with the guidance in ASC 480. Common stock subject to mandatory redemption is classified as a liability instrument
and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either
within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified
as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption
rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, common
stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of our condensed
balance sheets.
Net Income (Loss) Per Share of Common Stock
Net income
per common share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the period.
Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value
approximates fair value.
The Company has not considered the effect of the
Public Warrants and the Private Placement Warrants to purchase shares of common stock in the calculation of diluted net income (loss)
per share, since the exercise of such warrants into shares of common stock is contingent upon the occurrence of future events and their
inclusion would be anti-dilutive. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common
share for the periods presented.
Non-redeemable common stock includes the Founder
Shares and other shares of common stock that do not have redemption features.
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.